Rothschild & Co Asset Management US’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $8.13M | Sell |
666,214
-47,732
| -7% | -$583K | 0.12% | 125 |
|
|
2022
Q3 | $7.45M | Sell |
713,946
-158,654
| -18% | -$1.66M | 0.13% | 134 |
|
|
2022
Q2 | $9.37M | Sell |
872,600
-42,015
| -5% | -$451K | 0.14% | 125 |
|
|
2022
Q1 | $8.66M | Sell |
914,615
-299,502
| -25% | -$2.84M | 0.11% | 153 |
|
|
2021
Q4 | $14M | Sell |
1,214,117
-47,046
| -4% | -$543K | 0.16% | 140 |
|
|
2021
Q3 | $12M | Sell |
1,261,163
-146,768
| -10% | -$1.4M | 0.15% | 165 |
|
|
2021
Q2 | $13.6M | Buy |
1,407,931
+262,337
| +23% | +$2.53M | 0.16% | 162 |
|
|
2021
Q1 | $11.3M | Sell |
1,145,594
-336,873
| -23% | -$3.33M | 0.14% | 183 |
|
|
2020
Q4 | $34.2M | Sell |
1,482,467
-281,263
| -16% | -$6.49M | 0.44% | 64 |
|
|
2020
Q3 | $24.9M | Buy |
1,763,730
+19,273
| +1% | +$272K | 0.45% | 83 |
|
|
2020
Q2 | $26.3M | Sell |
1,744,457
-288,663
| -14% | -$4.35M | 0.39% | 97 |
|
|
2020
Q1 | $18.8M | Sell |
2,033,120
-167,787
| -8% | -$1.55M | 0.29% | 135 |
|
|
2019
Q4 | $21.4M | Buy |
2,200,907
+682,567
| +45% | +$6.65M | 0.22% | 185 |
|
|
2019
Q3 | $12.2M | Sell |
1,518,340
-16,083
| -1% | -$129K | 0.13% | 242 |
|
|
2019
Q2 | $19.2M | Buy |
1,534,423
+43,483
| +3% | +$543K | 0.2% | 190 |
|
|
2019
Q1 | $20.3M | Sell |
1,490,940
-30,399
| -2% | -$413K | 0.22% | 179 |
|
|
2018
Q4 | $14.6M | Buy |
1,521,339
+21,653
| +1% | +$207K | 0.18% | 206 |
|
|
2018
Q3 | $18.1M | Buy |
1,499,686
+1,264,173
| +537% | +$15.3M | 0.19% | 205 |
|
|
2018
Q2 | $3.68M | Buy |
235,513
+139,382
| +145% | +$2.18M | 0.04% | 311 |
|
|
2018
Q1 | $1.45M | Buy |
96,131
+3,622
| +4% | +$54.5K | 0.02% | 332 |
|
|
2017
Q4 | $1.33M | Buy |
+92,509
| New | +$1.33M | 0.01% | 332 |
|